Hearing on "Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities"
The Subcommittee on Health of the Committee on Energy and Commerce held a legislative hearing on Wednesday Febuary 1, 2023 at 10 a.m. in the John D. Dingell Hearing Room 2123 Rayburn House Office Building. The hearing is entitled “Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities.”
Key Document
Opening Statement from Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee Ranking Member Eshoo as prepared for delivery
Livestream
Legislation
H.R. 467, the "Halt All Lethal Trafficiking of Fentanyl Act" or the "HALT Fentanyl Act"
H.R. 498, the "9-8-8 Lifeline Cybersecurity Responsibillty Act
H.R. 501, the “Block, Report, And Suspend Suspicious Shipments Act”
H.R. 485, the “Protecting Health Care for All Patients Act of 2023”
Witnesses
Panel I:
Kemp Chester
Senior Advisor, International Relations and Supply Reduction
Office of National Drug Control Policy (ONDCP)
Dr. Neerja Gandotra
Chief Medical Officer
Substance Abuse and Mental Health Services Administration (SAMHSA)
Jon C. DeLena
Associate Administrator, Business Operations
Drug Enforcement Administration (DEA)
Panel II:
Kandi Pickard
President and CEO
National Down Syndrome Society (NDSS)
Frederick Isasi, J.D. MPH
Executive Director
Families USA
Molly Cain
Parent Advocate
Dr. Stephen Loyd, MD
Chief Medical Officer
Cedar Recovery
Dr. Timothy Westlake, MD
Emergency Medicine Physician